FDA Inspection 644680 — Genesis Biologics, Inc

Genesis Biologics, Inc — FEI 3007793345

The FDA completed an inspection of Genesis Biologics, Inc on Jan 27, 2010 in Newbury Park, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 27, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Newbury Park, CA (United States)

Citations

IDCFRDescription
1237221 CFR 1271.200(c)Calibrated per established schedules
1243121 CFR 1271.265(e)Procedures and release criteria

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.